Tiny magnetic microrobots, developed by ETH Zurich, precisely deliver drugs to stroke clots and tumors, achieving a 95% ...

Japanese researchers found that lecanemab, an amyloid-clearing drug for Alzheimer’s, does not improve the brain’s waste clearance system in the short term. This implies that nerve damage and impaired ...

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...

Over 1,000 healthcare experts gathered in Ho Chi Minh City and Hanoi to discuss the latest data on pneumococcal disease in ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

This article explores how understanding the brain–immune ecosystem brings insights to the molecular mechanisms behind brain ...

Like many of the chemicals and processes powering our bodies, the composition of the microbiome naturally fluctuates ...

Building a medtech startup is a long, costly, and often unforgiving journey. Most don’t make it past five years ...

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found ...

Researchers at Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, discovered that the ...